BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11097348)

  • 1. Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.
    Grahovac B; Bingulac-Popović J; Vucelić B; Hrstić I; Ostojić R; Drazić V; Balija M; Grgicević D
    Clin Chem Lab Med; 2000 Sep; 38(9):905-10. PubMed ID: 11097348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C.
    Grahovac B; Bingulac-Popovic J; Vucelic B; Hrstic I; Ostojic R; Drazic V; Balija M; Grgicevic D
    J Clin Virol; 2001 Jan; 20(1-2):85-9. PubMed ID: 11163588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapy.
    Al-Qahtani AA; Kessie G; Dela Cruz D; Al-Faleh FZ; Al-Ahdal MN
    Ann Saudi Med; 2010; 30(2):109-14. PubMed ID: 20220259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapy.
    González-Peralta RP; Liu WZ; Davis GL; Qian KP; Lau JY
    J Viral Hepat; 1997 Mar; 4(2):99-106. PubMed ID: 9097265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
    Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
    Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon].
    López-Labrador FX; Ampurdanès S; Giménez-Barcons M; Guilera M; Costa J; Jiménez de Anta MT; Sánchez-Tapias JM; Rodés J; Sáiz JC
    Hepatology; 1999 Mar; 29(3):897-903. PubMed ID: 10051495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment.
    von Wagner M; Lee JH; Rüster B; Kronenberger B; Sarrazin C; Roth WK; Zeuzem S
    J Viral Hepat; 2003 Nov; 10(6):413-22. PubMed ID: 14633173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study.
    Hino K; Yamaguchi Y; Fujiwara D; Katoh Y; Korenaga M; Okazaki M; Okuda M; Okita K
    J Viral Hepat; 2000 Jan; 7(1):36-42. PubMed ID: 10718941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of retreatment with interferon alone or interferon plus ribavirin on hepatitis C virus quasispecies diversification in nonresponder patients with chronic hepatitis C.
    Gerotto M; Sullivan DG; Polyak SJ; Chemello L; Cavalletto L; Pontisso P; Alberti A; Gretch DR
    J Virol; 1999 Sep; 73(9):7241-7. PubMed ID: 10438811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Viral quasispecies and their implications in antiviral therapy].
    Fernández B; Basaras M; Blanco S; Sánchez S; Arrese E; de las Heras B; Cisterna R
    Rev Esp Quimioter; 2002 Mar; 15(1):49-54. PubMed ID: 12582437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
    Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
    Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus genome complexity correlates with response to interferon therapy: a study in French patients with chronic hepatitis C.
    Le Guen B; Squadrito G; Nalpas B; Berthelot P; Pol S; Brechot C
    Hepatology; 1997 May; 25(5):1250-4. PubMed ID: 9141446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin.
    Bukowska-Ośko I; Pawełczyk A; Perlejewski K; Kubisa N; Caraballo Cortés K; Rosińska M; Płoski R; Fic M; Kaźmierczak J; Popiel M; Ząbek P; Horban A; Radkowski M; Laskus T
    PLoS One; 2015; 10(5):e0125604. PubMed ID: 25932941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of hepatitis C virus quasispecies during therapy with IL2 combinated to alpha interferon and ribavirin.
    Boulestin A; Sandres-Saune K; Alric L; Pipy B; Dubois M; Vinel JP; Izopet J
    Antivir Ther; 2005; 10(4):499-504. PubMed ID: 16038475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to combined interferon and ribavirin is better in patients infected with hepatitis C virus genotype 6 than genotype 1 in Hong Kong.
    Yuen MF; Lai CL
    Intervirology; 2006; 49(1-2):96-8. PubMed ID: 16166796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus.
    Kato T; Mizokami M; Nakano T; Orito E; Ohba K; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Fujita K; Yasuda K; Iino S
    J Med Virol; 1998 Jun; 55(2):109-17. PubMed ID: 9598930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.